Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EOG RESOURCES INC Director's Dealing 2022

Mar 4, 2022

29963_dirs_2022-03-03_abab8257-fbb7-42d5-8ec0-3800ef3cc19c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EOG RESOURCES INC (EOG)
CIK: 0000821189
Period of Report: 2022-03-02

Reporting Person: Helms Lloyd W Jr (President & COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-02 Common Stock M 3000 $95.05 Acquired 135930.863 Direct
2022-03-02 Common Stock D 2427 $117.50 Disposed 133503.863 Direct
2022-03-02 Common Stock F 140 $117.50 Disposed 133363.863 Direct
2022-03-02 Common Stock M 3000 $96.29 Acquired 136363.863 Direct
2022-03-02 Common Stock D 2459 $117.50 Disposed 133904.863 Direct
2022-03-02 Common Stock F 132 $117.50 Disposed 133772.863 Direct
2022-03-02 Common Stock M 8951 $75.09 Acquired 142723.863 Direct
2022-03-02 Common Stock D 5721 $117.50 Disposed 137002.863 Direct
2022-03-02 Common Stock F 786 $117.50 Disposed 136216.863 Direct
2022-03-02 Common Stock M 4529 $37.44 Acquired 140745.863 Direct
2022-03-02 Common Stock D 1444 $117.50 Disposed 139301.863 Direct
2022-03-02 Common Stock F 916 $117.50 Disposed 138385.863 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-02 Stock Appreciation Rights $95.05 M 3000 Disposed 2023-09-29 Common Stock (3000) Direct
2022-03-02 Stock Appreciation Rights $96.29 M 3000 Disposed 2024-09-25 Common Stock (3000) Direct
2022-03-02 Stock Appreciation Rights $75.09 M 8951 Disposed 2026-09-26 Common Stock (8951) Direct
2022-03-02 Stock Appreciation Rights $37.44 M 4529 Disposed 2027-09-28 Common Stock (4529) Direct

Footnotes

F1: The SARs granted became exercisable in 25% increments beginning one year from the September 29, 2016 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 29, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.

F2: The SARs granted became exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 25, 2017 date of grant. The SARs granted became fully exercisable on September 25, 2020. This exercise did not involve any open-market sale of the Issuer's Common Stock.

F3: The SARs granted become exercisable in increments of 33%, 33% and 34% on each of the first three anniversaries, respectively, of the September 26, 2019 date of grant. The SARs granted will become fully exercisable on September 26, 2022. This exercise did not involve any open-market sale of the Issuer's Common Stock.

F4: The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 28, 2020 date of grant. The SARs granted will become fully exercisable on September 28, 2023. This exercise did not involve any open-market sale of the Issuer's Common Stock.